Editors:
- Targeted therapy determined by molecular genetics is emphasized
- Role of molecular genetics in the CNS cancer development is discussed
- Advantages and limitations of biomarkers in tumor detection and diagnosis are detailed
- The role of translational medicine is emphasized (bench to bed)
- Can be used as an outside reading to obtain additional information at seminars and conferences in the medical field
- Teachers in medicine would be interested
Part of the book series: Tumors of the Central Nervous System (TCNS, volume 1)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (42 chapters)
-
Front Matter
-
Introduction
-
Front Matter
-
-
Biomarkers and Diagnosis
-
Front Matter
-
About this book
Reviews
From the reviews:
“This is an outstanding book on every molecular mediator of cancer stem cells, angiogenesis, surface markers, and CAD mediators of oncogenesis in the brain. … This is a very good book for neuropathologists and neurosurgeons.” (Joseph J. Grenier, Amazon.com, June, 2014)Editors and Affiliations
-
Dept. Biological Sciences, Kean University, Union, USA
M. A. Hayat
Bibliographic Information
Book Title: Tumors of the Central Nervous System, Volume 1
Book Subtitle: Gliomas: Glioblastoma (Part 1)
Editors: M. A. Hayat
Series Title: Tumors of the Central Nervous System
DOI: https://doi.org/10.1007/978-94-007-0344-5
Publisher: Springer Dordrecht
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer Science+Business Media B.V. 2011
Hardcover ISBN: 978-94-007-0343-8Published: 23 March 2011
Softcover ISBN: 978-94-007-3558-3Published: 23 April 2013
eBook ISBN: 978-94-007-0344-5Published: 23 March 2011
Series ISSN: 2215-096X
Series E-ISSN: 2215-0978
Edition Number: 1
Number of Pages: XXII, 434
Topics: Cancer Research, Neuroradiology, Neurosurgery, Oncology, Pathology, Surgery